Articles
- Page Path
- HOME > Osong Public Health Res Perspect > Volume 11(3); 2020 > Article
-
Corrigendum
Corrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90] -
Osong Public Health and Research Perspectives 2020;11(3):146-146.
DOI: https://doi.org/10.24171/j.phrp.2020.11.3.09
Published online: June 1, 2020
Korea Centers for Disease Control and Prevention, Cheongju, Korea
- *Corresponding author: COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention, Cheongju, Korea, E-mail: jeongek@korea.kr
Copyright ©2020, Korea Centers for Disease Control and Prevention
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
- 8,253 Views
- 98 Download
- 4 Crossref
This corrects the article "Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea" on page 85.
Table 3Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.
| Variables | n | (%) |
|---|---|---|
| Age, years, median (range) | 77 | (35–93) |
|
|
||
| Sex | ||
| Female | 29 | (43.9) |
| Male | 37 | (56.1) |
|
|
||
| Coexisting condition* | ||
| Any | 61 | (92.4) |
| Cerebrovascular disease | 5 | (7.6) |
| Heart disease | 10 | (15.2) |
| Pulmonary disease | 11 | (16.7) |
| Kidney disease | 5 | (7.6) |
| Diabetes | 23 | (34.8) |
| Hypertension | 30 | (45.4) |
| Cancer | 7 | (10.6) |
| Neurodegenerative disorder | 16 | (24.2) |
| Under investigation | 5 | (7.6) |
|
|
||
| Region | ||
| Daegu | 47 | (71.2) |
| Gyeongbuk | 16 | (24.2) |
| Others | 3 | (4.5) |
|
|
||
| Death before admission | 5 | (7.6) |
| Interval, days, median (range) | ||
| Symptom → Death | 10 | (1–24) |
| Symptom → Diagnosis | 4 | (0–20) |
| Symptom → Hospitalization | 4.5 | (0–11) |
| Hospitalization → Death | 5 | (0–16) |
|
|
||
| Total | 66 | |
Figure & Data
References
Citations
Citations to this article as recorded by 
- Effect of COVID-19-Related Interventions on the Incidence of Infectious Eye Diseases: Analysis of Nationwide Infectious Disease Incidence Monitoring Data
Woo-Ri Lee, Li-Hyun Kim, Gyeong-Min Lee, Jooyoung Cheon, Young Dae Kwon, Jin-Won Noh, Ki-Bong Yoo
International Journal of Public Health.2022;[Epub] CrossRef - Clinical Outcomes and Severity of Acute Respiratory Distress Syndrome in 1154 COVID-19 Patients: An Experience Multicenter Retrospective Cohort Study
Abbas Al Mutair, Saad Alhumaid, Laila Layqah, Jinan Shamou, Gasmelseed Y. Ahmed, Hiba Chagla, Khulud Alsalman, Fadhah Mohammed Alnasser, Koritala Thoyaja, Waad N. Alhuqbani, Mohammed Alghadeer, Mohammed Al Mohaini, Sana Almahmoud, Jaffar A. Al-Tawfiq, Jav
COVID.2022; 2(8): 1102. CrossRef - The Reopening of Schools and Adoption of Universal Wearing of Face Masks in Anticipation of Sustained Transmission or the Second Wave of COVID-19 with the Influenza Virus
Sasho Stoleski, Cameron Y. S. Lee
Journal of Public Health International.2020; 3(1): 1. CrossRef - Management of Diabetes in Coronavirus Disease 2019: Prognosis and Practical Issues
Hye Soon Kim
The Journal of Korean Diabetes.2020; 21(3): 120. CrossRef
PubReader
ePub Link
Cite
XML DownloadCorrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90]
Corrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90]
| Variables | n | (%) |
|---|---|---|
| Age, years, median (range) | 77 | (35–93) |
|
| ||
| Sex | ||
| Female | 29 | (43.9) |
| Male | 37 | (56.1) |
|
| ||
| Coexisting condition | ||
| Any | 61 | (92.4) |
| Cerebrovascular disease | 5 | (7.6) |
| Heart disease | 10 | (15.2) |
| Pulmonary disease | 11 | (16.7) |
| Kidney disease | 5 | (7.6) |
| Diabetes | 23 | (34.8) |
| Hypertension | 30 | (45.4) |
| Cancer | 7 | (10.6) |
| Neurodegenerative disorder | 16 | (24.2) |
| Under investigation | 5 | (7.6) |
|
| ||
| Region | ||
| Daegu | 47 | (71.2) |
| Gyeongbuk | 16 | (24.2) |
| Others | 3 | (4.5) |
|
| ||
| Death before admission | 5 | (7.6) |
| Interval, days, median (range) | ||
| Symptom → Death | 10 | (1–24) |
| Symptom → Diagnosis | 4 | (0–20) |
| Symptom → Hospitalization | 4.5 | (0–11) |
| Hospitalization → Death | 5 | (0–16) |
|
| ||
| Total | 66 | |
Table 3
Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.
A single case may have multiple comorbidities (investigation files required).
